Chronic diseases, not age, drive healthcare use NHP Forum: Preventing and treating osteoporosisExploring natural options for the treatment of osteoporosis. Adverse Reactions: Sibutramine - increased cardiovascular risks Sibutramine voluntarily withdrawn from Canadian and American markets in October 2010. Dermatology clinic: Depigmented patches more than a cosmetic issue Unearthing the latest in new drugs A look at novel agents in the late stages of development in Canada. Levothyroxine: best taken at bedtime Llevothyroxine improves thyroid hormone levels more when taken at bedtime compared to morning on empty stomach. New Health Canada DRIs for vitamin D and calcium Health Canada recommending Canadians follow new Dietary Reference Intakes for calcium and vitamin D. New drugs get a rise out of HDL Phase II trials look promising, but larger outcome studies needed Vitamin K may benefit bone Lowering urate cuts cardiovascular deaths Hyperuricemia deserves more aggressive treatment, researcher says First Previous 179 180 181 182 183 Next Last
